Add BrightSurf on Google Email

Université de Genève


How opioid drugs get into our cells

Researchers at UNIGE discovered that natural opioids cannot enter cells, whereas therapeutic opioids can, leading to differences in physiological responses. The study's findings could help develop safer medications with improved efficacy and reduced side effects.

SourceUniversité de Genève·JournalScience Advances·TypeNews article·DateApr 19, 2023

How music can prevent cognitive decline

A study found that practicing music and active listening can alter cognitive decline in healthy seniors by promoting brain plasticity. The researchers discovered an increase in grey matter volume in four brain regions involved in high-level cognitive functioning.

SourceUniversité de Genève·JournalNeuroImage·TypeNews article·DateApr 17, 2023

Tumor avatars to fight colorectal cancer

A UNIGE team created customizable treatments by testing drugs on artificial tumors derived from patients' cancer tissue. The approach opens the way for optimized and tailored therapies against various cancers and diseases.

SourceUniversité de Genève·JournalJournal of Experimental & Clinical Cancer Research·TypeNews article·DateApr 4, 2023

Shining a light into the ‘‘black box’’ of AI

An international team developed a novel method for evaluating AI interpretability methods to decipher the basis of AI reasoning and possible biases. The approach helps users understand what influences AI results and whether they can be trusted, especially in medical applications where AI-powered decisions can impact health and lives.

SourceUniversité de Genève·JournalNature Machine Intelligence·TypeNews article·DateMar 21, 2023

Sculpting quantum materials for the electronics of the future

Researchers at UNIGE have designed a quantum material that can be controlled by curving space, allowing for ultra-fast electromagnetic signal processing and potential applications in high-speed communication systems. The material's unique properties enable the creation of new sensors and potentially unlock new avenues in exploration.

SourceUniversité de Genève·JournalNature Materials·TypeNews article·DateMar 20, 2023

High-performance detectors to combat spies

A team from UNIGE and ID Quantique has developed single-photon detectors that can generate secret keys at a rate of 64 megabits per second, overcoming current limitations. This innovation enables ultra-secure data transfer for banks, healthcare systems, governments, and the military.

SourceUniversité de Genève·JournalNature Photonics·TypeNews article·DateMar 13, 2023

How to generate new neurons in the brain

Researchers at UNIGE and UNIL have discovered the importance of cell metabolism in reactivating quiescent neural stem cells, increasing new neurons in adult mice. This breakthrough could lead to potential treatments for conditions like depression and neurodegenerative diseases.

SourceUniversité de Genève·JournalScience Advances·TypeNews article·DateMar 1, 2023

An action plan to prevent Alzheimer’s disease

An international task force led by UNIGE and HUG has developed a preventive protocol to address the growing number of people affected by Alzheimer's disease. The guidelines focus on four pillars: risk assessment, risk communication, risk reduction, and cognitive enhancement.

SourceUniversité de Genève·JournalThe Lancet Regional Health - Europe·TypeNews article·DateJan 31, 2023

How to turn a tentacle into a foot

Researchers at UNIGE and FMI successfully modified the structure and function of tentacle cells in hydra by reducing Zic4 expression, resulting in transdifferentiation into foot cells. The study provides new insights into transdifferentiation mechanisms and could pave the way for therapies to regenerate deficient cell types in humans.

SourceUniversité de Genève·JournalScience Advances·TypeNews article·DateJan 5, 2023

Fighting cancer is more efficient at dawn

Researchers at UNIGE and LMU discovered that immune system's anti-tumour activity peaks in the morning. Tumours implanted at night grew faster than those implanted in the afternoon. Administering immunotherapy treatments early morning significantly enhanced their effectiveness, suggesting a new strategy for cancer treatment.

SourceUniversité de Genève·JournalNature·TypeNews article·DateDec 6, 2022

A new nanoparticle to act at the heart of cells

Researchers have developed a transport nanoparticle to deliver an anti-inflammatory drug, Necrosulfonamide (NSA), directly into macrophages to combat inflammatory overactivation. The mesoporous silica nanoparticle is fully biodegradable and non-toxic, showing remarkable efficacy in reducing inflammation.

SourceUniversité de Genève·JournalJournal of Controlled Release·TypeNews article·DateNov 8, 2022

Overcoming resistance to colon cancer treatment

Researchers at UNIGE have discovered a way to overcome resistance to chemotherapy in colorectal cancer, using an optimized combination of tyrosine kinase inhibitors. This breakthrough opens up new avenues for developing targeted therapies that can effectively treat patients with low five-year survival rates.

SourceUniversité de Genève·JournalCancers·TypeNews article·DateOct 27, 2022

A key regulator of cell growth deciphered

A team from the University of Geneva has identified the structure of the SEA complex, a key regulator of cell growth, and how it controls the activity of the major regulator of cell growth, mTOR. The discovery provides new insights into how cells perceive nutrient levels to regulate their growth.

SourceUniversité de Genève·JournalNature·TypeNews article·DateOct 27, 2022

The major chord that cures nightmares

A new therapy combining Imagery Rehearsal Therapy with Targeted Memory Reactivation has been shown to significantly reduce nightmare frequency and increase positive dreams in patients. The treatment, which involves associating a major piano chord with positive scenarios, resulted in lasting benefits even three months after the experiment.

SourceUniversité de Genève·JournalCurrent Biology·TypeNews article·DateOct 27, 2022

A revolutionary method to observe cell transport

Researchers developed a new method to study membrane proteins in their native environment, the cell, using electron spin resonance spectroscopy. This technique allows for precise determination of protein properties and could lead to better understanding and targeting of membrane proteins involved in anti-cancer drug resistance.

SourceUniversité de Genève·JournalScience Advances·TypeNews article·DateOct 24, 2022

Zinc could treat a rare genetic disorder

Researchers discovered that zinc can restore the functioning of proteins affected by mutations in the GNAO1 gene, leading to severe mental and motor disabilities. By reactivating hydrolysis, zinc enables neurons to communicate correctly with their environment.

SourceUniversité de Genève·JournalScience Advances·TypeNews article·DateOct 10, 2022

Awakening «dormant» cells to fight cancer

A team from UNIGE and HUG identified a protein regulation mechanism that reduces melanoma cells' capacity to adapt and resist treatment. They found that targeting this mechanism with an enzyme inhibitor reduces therapeutic resistance in all melanoma cells.

SourceUniversité de Genève·JournalBiochemical and Biophysical Research Communications·DateSep 22, 2022

Diabetes: When circadian lipid rhythms go wrong

A study by the University of Geneva team shows that disrupted circadian clocks lead to a rigidity in the membrane of pancreatic endocrine cells, affecting their function. The researchers also found that lipid profiles oscillate more during the day than previously thought, particularly in phospholipids and sphingolipids.

SourceUniversité de Genève·JournalPLOS Biology·TypeNews article·DateSep 19, 2022

Low addiction risk with medical use of ketamine

A recent study from the University of Geneva suggests that ketamine's therapeutic use may be safe due to its limited impact on dopamine levels and neuronal communication. The research found that ketamine triggers a short increase in dopamine, but also inhibits a specific receptor that prevents addiction progression.

SourceUniversité de Genève·JournalNature·TypeNews article·DateAug 4, 2022

Diabetes: a step closer to a life without insulin

Researchers at UNIGE have found that the S100A9 protein can significantly improve insulin metabolism in diabetic patients, reducing the risk of severe side effects associated with insulin therapy. The protein's anti-inflammatory effect may also help to normalize ketone production and prevent life-threatening conditions.

SourceUniversité de Genève·JournalNature Communications·DateJul 18, 2022

Neutrino factories in deep outer space

An international research team has shed light on the origin of neutrinos, shedding new evidence that blazars can be confidently associated with astrophysical neutrinos. The study utilizes neutrino data from the IceCube Neutrino Observatory and BZCat catalogue to establish a connection between high-energy neutrinos and galactic nuclei.

SourceUniversité de Genève·JournalThe Astrophysical Journal Letters·TypeData/statistical analysis·DateJul 14, 2022

How Omicron dodges the immune system

A study found that Omicron's neutralization capacity outperforms its predecessors, even in vaccinated individuals. Antibody levels against ancestral SARS-CoV-2 are roughly 10 times higher in vaccinated people than those with natural immunity.

SourceUniversité de Genève·JournalNature Communications·TypeNews article·DateJul 6, 2022

The Sun is spinning round again

An international team developed a new theoretical model that solves part of the 'solar problem' by considering the Sun's rotation and magnetic fields. The results reproduce the concentration of helium and lithium in the Sun's outer layers, providing insights into stellar physics.

SourceUniversité de Genève·JournalNature Astronomy·TypeNews article·DateMay 31, 2022

Cystic fibrosis: Restoring airway integrity

Researchers discovered that hydrating the surface of airways in people with cystic fibrosis restores their protective barrier against bacterial infections. This breakthrough opens the way to new therapies based on mucus hydration, offering a promising alternative to current treatments.

SourceUniversité de Genève·JournalCells·TypeNews article·DateMay 24, 2022

Our cells take their ease in the curves

A UNIGE team discovered that cells in curved tissues swell by 50% before returning to normal, opening avenues for in vitro organ culture. This active phenomenon can be harnessed to control spontaneous growth of organoids and develop new materials with volume increase upon folding.

SourceUniversité de Genève·JournalDevelopmental Cell·TypeNews article·DateMay 13, 2022

Failed eruptions are at the origin of copper deposits

Scientists from the University of Geneva discover that copper deposits are formed by mechanisms similar to those causing large volcanic eruptions. The 'porphyry' deposits, containing copper, form when hot fluids release from cooling magmas and develop under the earth's surface.

SourceUniversité de Genève·JournalCommunications Earth & Environment·TypeNews article·DateMay 9, 2022

Breast cancer: Why metastasis spreads to the bone

A team of biologists identified a protein involved in the spread of breast cancer to bones. The discovery confirms the importance of cellular plasticity during the metastatic process and could lead to new treatments. ZEB1, a protein that increases cell plasticity, was found to direct cells with metastatic characteristics to bones.

SourceUniversité de Genève·JournalNature Communications·TypeNews article·DateApr 21, 2022

Revolutionary images of the birth of crystals

Researchers have successfully visualized crystal nucleation, a crucial stage in crystallization, using Raman microspectroscopy and optical trapping. This breakthrough enables better understanding of molecular dynamics and may lead to the development of purer and more stable crystals for pharmaceuticals and other industries.

SourceUniversité de Genève·JournalProceedings of the National Academy of Sciences·TypeNews article·DateApr 21, 2022